News & Analysis on Biopharmaceutical Manufacturing & Bioprocessing Tech
CSL Behring: Paul McKenzie
By Ben Hargreaves & Maggie Lynch
- Last updated on
Paul McKenzie has been announced as CSL Behring’s COO, joining the haemophilia and immune deficiencies-focused biotech from Biogen.
At Biogen, McKenzie held the position of EVP of pharmaceutical operations and technology for over three years. Prior to this, he held similar roles at Janssen for eight years, BMS for 10 years, and Merck (known as MSD outside of the US and Canada) for six years.
In his role at CSL, he will be responsible for CSL’s global supply chain organisation, which includes its manufacturing process, engineering, and environmental responsibilities.
On his announcement, CSL noted that McKenzie is an “accomplished author and thought leader on operational excellence in the biotech industry.”